Cyrela (CYRE3, CYRE4) approved, at a Board of Directors meeting held on November 12, 2026, the cancellation of 27,327,161 common shares and 4,684,800 preferred shares held in treasury, totaling about 32 million shares. The board also approved the creation of a new buyback program of up to 24,152,061 common shares and up to 4,350,050 preferred shares.
The cancellation will be carried out without a reduction in share capital, which remains at R$ 6,184,224,000. The capital will be divided into 421,434,489 shares, of which 356,672,839 are common and 64,761,650 are preferred, all registered, book-entry and with no par value. Management will submit a proposal to the General Meeting in due course to amend Article 5 of the Bylaws to reflect the new number of shares.
The main purpose of the new program is to use available funds to purchase shares on the stock exchange, at market prices, to foster value creation for shareholders. The shares acquired may be held in treasury, canceled, subsequently sold on the market, or allocated to participants of share-based incentive plans that may be approved, without a reduction in share capital.
The previous buyback program, approved on June 5, 2026, has ended. Under it, 9,638,100 common shares and 4,684,800 preferred shares were acquired and will be canceled. The terms and conditions of the new program are detailed in the minutes of the meeting, available on the websites of the company, the CVM and B3.
Is CYRE3 worth investing in?
- Price
- R$ 19.45
- as of 11/11/2026
- Dividend yield
- 11.80 %
- P/L
- 4.32
- P/VPA
- 0.79
